Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Dan Simionescu and Narendra Vyavahare.
Dan Simionescu
Connection Strength
1.874
Narendra Vyavahare
  1. Biocompatibility and remodeling potential of pure arterial elastin and collagen scaffolds. Biomaterials. 2006 Feb; 27(5):702-13.
    View in: PubMed
    Score: 0.260
  2. Extracellular matrix degrading enzymes are active in porcine stentless aortic bioprosthetic heart valves. J Biomed Mater Res A. 2003 Sep 15; 66(4):755-63.
    View in: PubMed
    Score: 0.229
  3. Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration. J Heart Valve Dis. 2003 Mar; 12(2):217-25.
    View in: PubMed
    Score: 0.220
  4. Degeneration of bioprosthetic heart valve cusp and wall tissues is initiated during tissue preparation: an ultrastructural study. J Heart Valve Dis. 2003 Mar; 12(2):226-34.
    View in: PubMed
    Score: 0.220
  5. Osteogenic responses in fibroblasts activated by elastin degradation products and transforming growth factor-beta1: role of myofibroblasts in vascular calcification. Am J Pathol. 2007 Jul; 171(1):116-23.
    View in: PubMed
    Score: 0.074
  6. Elastin stabilization for treatment of abdominal aortic aneurysms. Circulation. 2007 Apr 03; 115(13):1729-37.
    View in: PubMed
    Score: 0.073
  7. Neomycin prevents enzyme-mediated glycosaminoglycan degradation in bioprosthetic heart valves. Biomaterials. 2007 Jun; 28(18):2861-8.
    View in: PubMed
    Score: 0.073
  8. In vivo cellular repopulation of tubular elastin scaffolds mediated by basic fibroblast growth factor. Biomaterials. 2007 Jun; 28(18):2830-8.
    View in: PubMed
    Score: 0.073
  9. Toward cell therapy for vascular calcification: osteoclast-mediated demineralization of calcified elastin. Cardiovasc Pathol. 2007 Jan-Feb; 16(1):29-37.
    View in: PubMed
    Score: 0.072
  10. Glycosaminoglycan-targeted fixation for improved bioprosthetic heart valve stabilization. Biomaterials. 2007 Jan; 28(3):496-503.
    View in: PubMed
    Score: 0.071
  11. Structural requirements for stabilization of vascular elastin by polyphenolic tannins. Biomaterials. 2006 Jul; 27(19):3645-51.
    View in: PubMed
    Score: 0.068
  12. Elastin calcification in the rat subdermal model is accompanied by up-regulation of degradative and osteogenic cellular responses. Am J Pathol. 2006 Feb; 168(2):490-8.
    View in: PubMed
    Score: 0.067
  13. Stability and function of glycosaminoglycans in porcine bioprosthetic heart valves. Biomaterials. 2006 Mar; 27(8):1507-18.
    View in: PubMed
    Score: 0.066
  14. Tannic acid treatment enhances biostability and reduces calcification of glutaraldehyde fixed aortic wall. Biomaterials. 2005 Apr; 26(11):1237-45.
    View in: PubMed
    Score: 0.064
  15. Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinases. Circulation. 2004 Nov 30; 110(22):3480-7.
    View in: PubMed
    Score: 0.062
  16. Novel porous aortic elastin and collagen scaffolds for tissue engineering. Biomaterials. 2004 Oct; 25(22):5227-37.
    View in: PubMed
    Score: 0.062
  17. Elastin stabilization in cardiovascular implants: improved resistance to enzymatic degradation by treatment with tannic acid. Biomaterials. 2004 Jul; 25(16):3293-302.
    View in: PubMed
    Score: 0.060
  18. Involvement of matrix metalloproteinases and tenascin-C in elastin calcification. Cardiovasc Pathol. 2004 May-Jun; 13(3):146-55.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.